This cohort study evaluates frequencies and predictors of discontinuation of injectable semaglutide in older adults with diabetes in the US and Japan.

Sepsis is a life-threatening condition that demands prompt treatment for improved patient outcomes. Its heterogenous presentation makes early detection challenging, highlighting the need for effect...

Because of misperceptions about risks, people with sickle cell trait in the United States may receive inequitable and potentially harmful treatment, with implications for autonomy, privacy, and ...

BIDMC researchers find that 137 million adults are eligible for semagludtide for weight loss, diabetes management or recurrent cardiovascular event prevention.